These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32138790)

  • 1. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).
    Farkas B; Boldizsar F; Bohonyi N; Farkas N; Marczi S; Kovacs GL; Bodis J; Koppan M
    J Ovarian Res; 2020 Mar; 13(1):25. PubMed ID: 32138790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome.
    Manolopoulos K; Lang U; Gips H; Braems GA
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):226-31. PubMed ID: 11788177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome.
    Friedlander MA; Loret de Mola JR; Goldfarb JM
    Fertil Steril; 1993 Nov; 60(5):826-33. PubMed ID: 8224268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Friedler S; Nisman B; Barak V
    Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Elhelw BA; Shaarawy M
    Hum Reprod; 1998 Aug; 13(8):2068-71. PubMed ID: 9756270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome.
    Revel A; Barak V; Lavy Y; Anteby E; Abramov Y; Schenker JJ; Amit A; Finci-Yeheskel Z; Mayer M; Simon A; Laufer N; Hurwitz A
    Fertil Steril; 1996 Jul; 66(1):66-71. PubMed ID: 8752613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management.
    Delbaere A; Bergmann PJ; Gervy-Decoster C; Staroukine M; Englert Y
    Fertil Steril; 1994 Oct; 62(4):731-7. PubMed ID: 7926081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
    Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
    J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD11c+HLA-DR+dendritic cells and related cytokines in the follicular fluid might be related to pathogenesis of ovarian hyperstimulation syndrome.
    Shi SL; Peng ZF; Yao GD; Jin HX; Song WY; Yang HY; Xue RY; Sun YP
    Int J Clin Exp Pathol; 2015; 8(11):15133-7. PubMed ID: 26823856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y; Barak V; Nisman B; Schenker JG
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V
    Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intercellular adhesion molecule-1 and E-selectin in the pathogenesis of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Gemer O; Cherneva S
    Akush Ginekol (Sofiia); 2005; 44(4):26-31. PubMed ID: 16028375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
    Itskovitz-Eldor J; Kol S; Lewit N; Sealey JE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):461-4. PubMed ID: 9024237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome.
    Abramov Y; Naparstek Y; Elchalal U; Lewin A; Schechter E; Schenker JG
    Fertil Steril; 1999 Jan; 71(1):102-5. PubMed ID: 9935124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
    Grynnerup AG; Toftager M; Zedeler A; Bogstad JW; Prætorius L; Grøndahl ML; Yding Andersen C; Sørensen S; Pinborg A; Løssl K
    J Assist Reprod Genet; 2018 Dec; 35(12):2187-2193. PubMed ID: 30232642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.